COMPOSITE LYMPHOMA

Clinical trials for COMPOSITE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new COMPOSITE LYMPHOMA trials appear

Sign up with your email to follow new studies for COMPOSITE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Three-Drug attack on tough lymphomas

Disease control Ongoing

This study is testing a new three-drug combination to control B-cell non-Hodgkin lymphoma. It aims to find the safest dose and see if adding a new immunotherapy drug (ALX148) to two existing drugs (rituximab and lenalidomide) helps patients whose cancer has returned or is newly d…

Matched conditions: COMPOSITE LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

COMPOSITE LYMPHOMA

Get alerted when new COMPOSITE LYMPHOMA trials appear

New Three-Drug attack on tough lymphomas